MEDICON & CMBEBIH 2023
The conference organisation was supported by the Government of the Federation of Bosnia and Herzegovina, Ministry of Science, Higher-Education and and Youth of Sarajevo Canton, Ministry of Health of Sarajevo Canton, City of Sarajevo, European Union Delegation to Bosnia and Herzegovina, Government of the Federal Republic of Germany, as well as the sponsorship by the Member of Presidency of Bosnia and Herzegovina, Dr. Denis Bećirović.
The conference was organised by the Society for Medical and Biological Engineering in Bosnia and Herzegovina in cooperation with Verlab Research Institute and other partners.
Digital transformation of the production process
Team member:
Merima Smajlhodžić-Deljo, Expert Associate
Its4Health - Digital Innovation Hub
About its4Health
DIH its4Health in BIH is a vital component of the larger EU4DigitalSME initiative. It strives to foster a digitalized, automated, and innovative environment within small and medium-sized enterprises (SMEs). This Hub is dedicated to expediting the eco-friendly and digital evolution of healthcare in BIH, collaborating across public and private sectors. Its overarching goal is to revolutionize patient outcomes through innovative practices.
The Hub’s Partnership Framework
The central collaborative structure of the Hub involves a partnership between the University Sarajevo School of Science and Technology (SSST), the Verlab Research Institute for Biomedical Engineering, Medical Devices, and Artificial Intelligence (VERLAB), along with the Institute of Metrology of BIH (IMBiH) and the Institute for Standardisation of BiH (ISBIH). This alliance harnesses extensive research capacities alongside industry insight and policy expertise, creating a robust platform for knowledge exchange and innovation.
IG17104 - Pan-European Educational Platform on Multidrug Resistant Tumours and Personalised Cancer Treatment
Multidrug resistance (MDR) affects 30 to 60% of cancer patients, causing poor quality of life and high costs for healthcare systems. Research in the MDR field is highly fragmented, and there is no professional figure of young scientists that are adequately instructed in the different disciplines, trained to have interdisciplinary and transdisciplinary views and approaches that cover preclinical and clinical research in MDR tumours in order to successfully develop diagnostic tests or new drugs for MDR tumours. This CIG aims to create this new professional figure. By exploiting the scientific excellence present in our COST Action and the experience accumulated in organising training schools, practical-theoretical courses and workshops for young scientists, the CIG aims to create a prototype for a training platform that will allow each scientist to fill the gaps in her/his scientific knowledge, and acquire a broader set of skills and expertise that will be advantageous at multiple levels.
CA18131 - Statistical and machine learning techniques in human microbiomestudies (ML4Microbiome)
This COST Action network will create productive symbiosis between discovery-oriented microbiome researchers and data-driven ML experts, through regular meetings, workshops and training courses. Together, it will first optimise and then standardise the use of said techniques, following the creation of publicly available benchmark datasets. Correct usage of these approaches will allow for better identification of predictive and discriminatory ‘omics’ features, increase study repeatability, and provide mechanistic insights into possible causal or contributing roles of the microbiome.
- CA21116 - Identification of biological markers for prevention and translational medicine in pancreatic cancer (TRANSPAN)
- CA20140 - CorEuStem: The European Network for StemCell Core Facilities (CorEuStem)
- CA20124 - Maximising impact of multidisciplinary research in early diagnosis of neonatal brain injury (AI-4-NICU)
